Table 2.
One-year unadjusted and multivariable adjusted mortality hazard ratios associated with black vs. white race
1 y | 2 y | 3 y | 4 y | 5 y | ||||||
---|---|---|---|---|---|---|---|---|---|---|
unadjusted | adjusted | unadjusted | adjusted | unadjusted | adjusted | unadjusted | adjusted | unadjusted | adjusted | |
Overall | 1.19 (1.14–1.23) | 0.77(0.73–0.81) | 0.97 (0.94–1.01) | 0.70 (0.67–0.73) | 0.93 (0.90–0.97) | 0.71 (0.68–0.74) | 0.93 (0.89–0.97) | 0.74 (0.70–0.77) | 0.99 (0.93–1.05) | 0.88 (0.82–0.94) |
CKD stage | ||||||||||
3a | 1.25 (1.19–1.32) | 0.81 (0.75–0.88) | 1.01 (0.96–1.07) | 0.73 (0.68–0.78) | 0.98 (0.93–1.03) | 0.71 (0.67–0.76) | 0.93 (0.88–0.98) | 0.72 (0.68–0.77) | 1.03 (0.95–1.11) | 0.88 (0.81–0.97) |
3b | 1.06 (0.99–1.13) | 0.72 (0.65–0.79) | 0.91 (0.86–0.98) | 0.68 (0.62–0.74) | 0.85 (0.79–0.91) | 0.69 (0.63–0.75) | 0.90 (0.83–0.97) | 0.74 (0.68–0.81) | 0.86 (0.77–0.96) | 0.81 (0.71–0.92) |
4 | 0.90 (0.81–0.99) | 0.76 (0.66–0.87) | 0.73 (0.66–0.81) | 0.68 (0.59–0.78) | 0.71 (0.63–0.79) | 0.66 (0.58–0.76) | 0.80 (0.70–0.91) | 0.79 (0.69–0.92) | 0.96 (0.79–1.17) | 1.01 (0.81–1.27) |
5 | 0.79 (0.66–0.94) | 0.78 (0.6–1.02) | 0.51 (0.42–0.63) | 0.63 (0.47–0.83) | 0.55 (0.55–0.68) | 0.78 (0.59–1.03) | 0.47 (0.36–0.62) | 0.52 (0.36–0.75) | 0.70 (0.48–1.03) | 0.83 (0.48–1.44) |
NOTE: Values shown in parentheses are 95% confidence intervals. Associations in the first, second, third, fourth and fifth year of follow-up, conditional on surviving to the beginning of the examined year, overall and in subgroups of patients with different stages of CKD at baseline. CKD stages 3a, 3b, 4 and 5 include patients with estimated glomerular filtration rates of 45–59.9, 30–44.9, 15–29.9, and <15 ml/min/1.73 m2, respectively.
CKD, chronic kidney disease.